Exploring Biotin-SN38-Valproic Acid Conjugates as a targeted cancer therapy approach combining chemotherapy, epigenetic modulation, and precise delivery.
Novel DNA-PK inhibitor combined with radiation therapy demonstrates potent synergy against glioblastoma and lung cancer in preclinical studies.